Search - tctmd.com

Displaying 1 - 20 of 129

Sort: Relevancy | Date

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Daily News

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

L.A. McKeown

August 16, 2021

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

News Conference News CRT 2021

Polymer-Free Stent Noninferior to ZES at 3 Years: ReCre8

Yael L. Maxwell

March 18, 2021

News Conference News TCT 2020

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Todd Neale

October 15, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Daily News

Volume-Outcome Relationship Questioned in CHIP PCI for Stable Angina

Todd Neale

February 13, 2020

News Industry News

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

October 09, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

News Conference News EuroPCR 2019

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Caitlin E. Cox

May 23, 2019

Podcast TCTMD Talking Points

BIONYX: A Thin Composite-Wire Strut, Durable Polymer-Based DES Compared With an Ultrathin-Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

February 20, 2019

Advertisement

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

CABG and PCI Comparable in ACS Patients With Left Main CAD

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Polymer-Free Stent Noninferior to ZES at 3 Years: ReCre8

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Volume-Outcome Relationship Questioned in CHIP PCI for Stable Angina

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

BIONYX: A Thin Composite-Wire Strut, Durable Polymer-Based DES Compared With an Ultrathin-Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content